ClaimsPeople

Dario Amodei

Dario Amodei is co-founder and CEO of Anthropic and a former VP of Research at OpenAI, where he led work on GPT-2 and GPT-3.

1,335 claims collected, 337 researched, 97 resolved. Report of 4 November 2026, method 0.1.0+c876030c.

Scores by kind of claim

Each kind of claim is scored on its own, out of 100: the share that held up, with the range it likely falls in. Fewer resolved claims give a wider range.

  • Factual claims

    Statements about the present or the past, checked against the record: did they hold up?

    76 69 82

    High confidence, 76 factual claims resolved. From 14 documents, 2015 to 2026; 19 documents sampled from 30 candidates found.

    Not scored: 51 unresolvable, 42 checkable only against their own records.

  • Predictions

    Statements about events outside the person's control, checked once they fell due: did they come true?

    56 42 70

    Medium confidence, 17 predictions resolved. From 8 documents, 2015 to 2026; 19 documents sampled from 30 candidates found.

    Not scored: 103 unresolvable, 1 checkable only against their own records. 39 more fall due later.

    Does not yet allow for how likely each prediction was when made.

  • Promises

    Commitments to the person's or organisation's own future action, with something to deliver: was it delivered?

    Insufficient record: 4 promises resolved, 5 needed for a score.

    Not scored: 3 unresolvable, 1 not yet due.

All types combined: 72 (likely 66 to 78, high confidence), from 93 claims: 76 factual claims, 17 predictions. It mixes kinds of claim in different proportions for different people, so compare people kind by kind.

Dario Amodei's claims

337 claims, sorted by newest said. Choose a claim to read it in full.
VerdictKindSaidClaimTopic
Unresolvable Factual 17 Aug 2015 Successful biology projects are often scrappy or afterthoughts not initially thought promising, rather than massively funded efforts. Factual · 17 Aug 2015 Science and research methods
Not yet due Prediction 17 Aug 2015 The human economy may continue to make sense a little past the point where AI reaches a 'country of geniuses in a datacenter'. Prediction · 17 Aug 2015 AI, the economy and work
Unresolvable Prediction 17 Aug 2015 There is a good chance Alzheimer's can eventually be prevented with relatively simple interventions once what is going on is actually understood. Prediction · 17 Aug 2015 Science and research methods
Unresolvable Prediction 17 Aug 2015 AI could enable reductions of 95% or more in both cancer mortality and incidence. Prediction · 17 Aug 2015 AI capabilities
Not yet due Prediction 17 Aug 2015 Amodei guessed that powerful AI could at least 10x the rate of these biological discoveries, giving the next 50-100 years of biological progress in 5-10 years. Prediction · 17 Aug 2015 Science and research methods
Unresolvable Prediction 17 Aug 2015 Amodei expects improvements in mental health, well-being and education to increase democracy, citing that all three are negatively correlated with support for authoritarian leaders. Prediction · 17 Aug 2015 Philosophy, ethics and society
Unresolvable Prediction 17 Aug 2015 The basic development of AI technology and many, though not all, of its benefits seems inevitable unless the risks derail everything, and is fundamentally driven by powerful market forces. Prediction · 17 Aug 2015 AI timelines and forecasting
Unresolvable Prediction 17 Aug 2015 Amodei strongly suspects that details of individual neuron communication will be abstracted away in most interesting questions about computation and circuits. Prediction · 17 Aug 2015 Science and research methods
Mostly true Factual 17 Aug 2015 Diseases have been eradicated and many countries have gone from poor to rich, through decisions that exhibit high returns to intelligence. Factual · 17 Aug 2015 Economics and markets
Unresolvable Prediction 17 Aug 2015 Amodei said he does not think governments will (or should) turn over their economic policy to an AI, even if it could do so; he also said he is somewhat skeptical that an AI could solve the socialist calculation problem. Prediction · 17 Aug 2015 AI, the economy and work
Mostly true Factual 17 Aug 2015 Although drug development is overly cumbersome, once developed drugs are generally successfully deployed and used. Factual · 17 Aug 2015 Economics and markets
Unresolvable Factual 17 Aug 2015 In recent years GWAS studies seem to suggest that correlations between psychiatric disease genes and positive traits might have been overstated. Factual · 17 Aug 2015 Science and research methods
Unresolvable Factual 17 Aug 2015 Over the last 30 years, mathematicians, computer scientists and physicists applying their skills to biology have been quite successful but have not had the truly transformative impact initially hoped for. Factual · 17 Aug 2015 Science and research methods
Unresolvable Prediction 17 Aug 2015 Greatly improved embryo screening will likely make it possible to prevent most genetic disease. Prediction · 17 Aug 2015 Science and research methods
Unresolvable Prediction 17 Aug 2015 In the short term, comparative advantage will keep humans relevant and increase their productivity as AI advances. Prediction · 17 Aug 2015 AI, the economy and work
Unresolvable Prediction 17 Aug 2015 It is plausible that "AI finance ministers and central bankers" could replicate or exceed the "10% accomplishment" that the surrounding text credits to human economic planners whose policy choices helped countries catch up with the developed world. Prediction · 17 Aug 2015 AI, the economy and work
Unresolvable Prediction 17 Aug 2015 Once AI is broadly effective and cheap, the current economic setup will no longer make sense and a broader societal conversation on organizing the economy will be needed. Prediction · 17 Aug 2015 AI, the economy and work
Unresolvable Prediction 17 Aug 2015 AI-enabled biological science may reduce the need for iteration in clinical trials by developing more accurate animal and cell models or simulations. Prediction · 17 Aug 2015 Science and research methods
Not yet due Prediction 17 Aug 2015 Amodei guessed that diseases like PTSD, depression, schizophrenia and addiction can be figured out and very effectively treated. Prediction · 17 Aug 2015 Science and research methods
Unresolvable Prediction 17 Aug 2015 The triumph of liberal democracy and political stability is not guaranteed and perhaps not even likely. Prediction · 17 Aug 2015 Philosophy, ethics and society
Not yet due Prediction 17 Aug 2015 While AI is better at only 90% of a given job, the remaining 10% will make humans highly leveraged, raise compensation and create new complementary human jobs. Prediction · 17 Aug 2015 AI, the economy and work
Unresolvable Prediction 17 Aug 2015 Amodei said he is open to the perhaps absurd-sounding idea that 1000 years of progress could happen in 5-10 years, but very skeptical that 100 years of progress could happen in 1 year. Prediction · 17 Aug 2015 Science and research methods
Not yet due Prediction 17 Aug 2015 AI-accelerated neuroscience is likely to vastly improve treatments for, or cure, most mental illness and expand cognitive and mental freedom. Prediction · 17 Aug 2015 AI capabilities
Unresolvable Prediction 17 Aug 2015 Once human lifespan reaches 150, longevity 'escape velocity' may be reached so most people alive today could live as long as they want. Prediction · 17 Aug 2015 Science and research methods
Mixed Factual 17 Aug 2015 Human economic planners made the decisions that led to several East Asian economies' late-20th-century growth by pulling a few key levers such as export-led industrial policy, not by directly controlling whole economies. Factual · 17 Aug 2015 Economics and markets
Unresolvable Prediction 17 Aug 2015 In the long run AI will become so broadly effective and cheap that human comparative advantage will no longer keep the current economy sensible. Prediction · 17 Aug 2015 AI, the economy and work
Unresolvable Factual 17 Aug 2015 Markets function better in the developed world and are typically good at bringing down the cost of high-value technologies over time. Factual · 17 Aug 2015 Economics and markets
Not yet due Prediction 17 Aug 2015 Amodei thinks 5-10 years after powerful AI is a reasonable timeline for a good fraction (maybe 50%) of AI-driven health benefits to reach even the poorest countries in the world. Prediction · 17 Aug 2015 AI capabilities
Unresolvable Factual 17 Aug 2015 There is perhaps about one major biology discovery per year, and collectively these arguably drive over 50% of progress in biology. Factual · 17 Aug 2015 Science and research methods
Unresolvable Prediction 17 Aug 2015 There is good reason to think AI-enhanced research will give us the means to make mitigating climate change far less costly and disruptive. Prediction · 17 Aug 2015 AI capabilities
Mixed Factual 17 Aug 2015 Smallpox was fully eliminated in the 1970s, and polio and guinea worm are nearly eradicated with fewer than 100 cases per year. Factual · 17 Aug 2015 Biosecurity
Not yet due Prediction 17 Aug 2015 Mind uploading is almost certainly possible in principle but likely will not be achieved within the 5-10 year window of powerful AI. Prediction · 17 Aug 2015 Science and research methods
Unresolvable Prediction 17 Aug 2015 AI can likely do disease eradication and economic development tasks better than they are currently done. Prediction · 17 Aug 2015 AI, the economy and work
Not yet due Prediction 17 Aug 2015 Because cancer death rates have fallen about 2% per year for decades, humanity is on track to eliminate most cancer in the 21st century at the current pace of science. Prediction · 17 Aug 2015 Science and research methods
Unresolvable Prediction 17 Aug 2015 If 20% annual GDP growth were achieved in the developing world, sub-Saharan Africa would reach China's current per-capita GDP in 5-10 years. Prediction · 17 Aug 2015 Economics and markets
Unresolvable Prediction 17 Aug 2015 Humans are likely to keep a relative or even absolute advantage over AI in the physical world for a significant time. Prediction · 17 Aug 2015 AI, the economy and work
Unresolvable Factual 17 Aug 2015 Dario Amodei thinks and talks a lot about the risks of powerful AI. Factual · 17 Aug 2015 Their own work or organisation
Back to the list

Dario Amodei

Open its page

Factual Economics and markets

“First, markets function better in the developed world, and markets are typically good at bringing down the cost of high-value technologies over time”

Dario Amodei, essay author 17 August 2015 Machines of Loving Grace (darioamodei.com)

Markets function better in the developed world and are typically good at bringing down the cost of high-value technologies over time.

Unresolvable The public record could not settle it.

What would count as true or false

Judge as a general economic claim as of 2015-08-17, with two parts: (a) markets work better in developed countries than in less developed ones; (b) markets typically bring down the cost of high-value technologies over time. True: mainstream economic evidence (institutional quality, market-efficiency indices, development economics literature) supports both parts as general tendencies, and evidence on price declines for technologies (computing, solar, drugs after patents expire, telecoms) supports 'typically'. Mostly true: both parts hold broadly, with notable but minor exceptions acknowledged in the literature. Mixed: one part is well supported and the other is contested or weakly supported. Mostly false: both parts rest on real tendencies but are materially overstated (for example cost declines are typical only for a narrow class of technologies). False: the evidence shows that markets do not function better in developed economies, or that market forces do not generally lower costs of high-value technologies.

Evidence

  1. LEARNING CURVES FOR ENERGY TECHNOLOGY: A CRITICAL ASSESSMENT University of Cambridge (Tooraj Jamasb and Jonathan Köhler) · October 2007
    “unit cost reductions of 20% associated with doubling of capacity has been typical for energy generation technologies, with the exception of nuclear power.”
  2. LEARNING CURVES FOR ENERGY TECHNOLOGY: A CRITICAL ASSESSMENT University of Cambridge (Tooraj Jamasb and Jonathan Köhler) · October 2007
    “We argue that learning curves have often been used or assumed uncritically in technology analysis”
  3. The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review PubMed Central (National Library of Medicine) · 17 July 2018
    “The identified studies indicated that drug prices decreased significantly after patent expiry with drug price ratios ranging from 6.6 to 66% 1–5 years after patent expiry.”
  4. The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review PubMed Central (National Library of Medicine) · 17 July 2018
    “The 16 identified studies that assessed impact of patent expiry on drug prices showed that price developments after patent expiration varied between countries.”
  5. Learning Curves for Energy Technology: A Critical Assessment University of Cambridge repository (authors: Tooraj Jamasb, Jonathan Köhler) · October 2007
    “unit cost reductions of 20% associated with doubling of capacity has been typical for energy generation technologies, with the exception of nuclear power.”
  6. Learning Curves for Energy Technology: A Critical Assessment University of Cambridge repository (authors: Tooraj Jamasb, Jonathan Köhler) · October 2007
    “Negative estimates have even been reported for technologies when they have been subject to costly regulatory restrictions over time (e.g. nuclear, and coal if flue gas desulphurization costs are not separated), and for price-based (as opposed to cost-based) learning rates in some periods reflecting aspects of market behavior.”
  7. The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review PubMed Central (NCBI), peer-reviewed journal article · 17 July 2018
    “showed that price developments after patent expiration varied between countries”
  8. The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review PubMed Central (NCBI), peer-reviewed journal article · 17 July 2018
    “the four studies that focused on the USA concluded that originator prices were rigid and overall did not alter significantly after patent expiry”
  9. Nuclear Power Learning and Deployment Rates; Disruption and Global Benefits Forgone MDPI (Energies), author Peter A. Lang · 18 December 2017
    “From 1954 to the late-1960s, learning rates of nuclear power OCC were positive (i.e., OCC decreased as capacity increased). In the late-1960s, learning rates turned negative (i.e., OCC increased as capacity increased) and have remained negative ever since in all the seven countries analysed, except South Korea.”
  10. Nuclear Power Learning and Deployment Rates; Disruption and Global Benefits Forgone MDPI (Energies), author Peter A. Lang · 18 December 2017
    “A likely root-cause of many of the causes discussed in the literature was the growing concern about the safety of nuclear power, fanned by the anti-nuclear protest movement, which began in the mid-1960s (Daubert and Moran [27]; Wyatt [28]), and the ongoing political, legislative and regulatory responses to the concerns.”

Reasoning

For part (b), the evidence supports cost declines over time but with notable exceptions. Energy generation technologies typically showed about 20% unit cost reductions per doubling of capacity (E1). Drug prices generally fell after patent expiry (E3), but outcomes varied by country, and US originator prices stayed rigid (E4, E8). Negative learning estimates have been reported for nuclear power under costly regulatory restrictions (E6), and nuclear construction costs rose with capacity from the late 1960s onward in six of the seven countries analysed, South Korea being the exception (E9). For part (a), no evidence compares how well markets function in developed and less developed economies, so the two-part criteria cannot be settled.

Cite this claim

Dario Amodei, “Markets function better in the developed world and are typically good at bringing down the cost of high-value technologies over time.” (said 17 August 2015). Verdict: unresolvable. Reliability API, claim c_d960030dbae7, method 0.1.0+c876030c. https://epistacklabs.com/claims/c_d960030dbae7

Claims without a verdict

Is a verdict here wrong, or do you speak for Dario Amodei? Reply on the claim's own page, with the form at its foot (how replies work). Verdicts are made automatically; how verdicts and scores are made.